HEADSpAcE
The Translational Studies of Head and Neck Cancer in South America and Europe (HEADSpAcE) project is a unique study that will investigate multiple reasons for the poor prognosis of head and neck cancers, including individual and structural reasons for late diagnosis. A major reason for the high mortality rate of head and neck cancers is the late stage at diagnosis for many patients. The impact of HEADSpAcE will be to elucidate reasons for late diagnosis and reduce the proportion of head and neck cancers that are diagnosed at a very late stage. Guidelines will be developed for implementation in clinical care. HEADSpAcE is funded by the European Commission and brings together a consortium of 18 partner institutions from four continents.
Integrative Analysis of Lung Cancer Etiology and Risk
This project focuses on evaluating a comprehensive panel of biomarkers of lung cancer risk that have been implicated in previous studies and the extent to which they may inform risk prediction. This is achieved by bringing together data from ongoing large-scale biomarker studies and conducting a comprehensive analysis of promising risk biomarkers within the Lung Cancer Cohort Consortium (LC3).